4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-135571
Chief Scientific Officer sold 2,334 shares at $28.12 ($65,632)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-12-11 | Sale 10b5-1 | −2,334 | $28.12 | $65,632 | 201,685 | D |
| Open-market sales · 2,334 sh · avg $28.12 · $65,632 | |||||||
Loading xslF345X05/ownership.xml…